Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2020 Aug;61(8):1989-1995.
doi: 10.1080/10428194.2020.1742910. Epub 2020 Mar 31.

An effective early death scoring system for predicting early death risk in de novo acute promyelocytic leukemia

Affiliations
Randomized Controlled Trial

An effective early death scoring system for predicting early death risk in de novo acute promyelocytic leukemia

Ping Cai et al. Leuk Lymphoma. 2020 Aug.

Abstract

The Sanz risk, which was originally used to predict the risk of acute promyelocytic leukemia (APL) relapse, is a recognized method to predict the prognosis of APL. About 570 de novo APL patients admitted to our center were randomly divided into a training cohort (N = 344) and validation cohort (N = 226). Multivariate analysis of training cohort demonstrated that age >52 (OR = 5.170, p = .002), white blood cell count >10 × 109/L (OR = 9.062, p < .001), PLT count ≤10 × 109/L (OR = 4.254, p < .001), and LDH level >500 U/L (OR= 3.002, p = .046) were independent risk factors for early death. A risk score (age >52: 1.5 points; WBC >10 × 109/L: 2 points; PLT ≤10 × 109/L: 1 point; LDH >500 U/L: 1 point) was used to predict early death risk. The model shows a better predictive power of early death in training cohort and validation cohort compared with Sanz risk stratification.

Keywords: Acute promyelocytic leukemia; early death; risk score.

PubMed Disclaimer

Publication types

LinkOut - more resources